Detection of MEN1 resistance mutations in cell-free DNA from acute…
Blood tests can now detect when leukemia patients develop resistance to cutting-edge menin inhibitor drugs, enabling faster treatment adjustments without invasive procedures.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Multi-omic analysis of deep learning-derived phenotypes links…
Retinal eye imaging combined with genetic data reveals cardiovascular and brain disease risk, opening a non-invasive screening pathway for millions.
Underserved or high-risk populationsAllogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia
Younger patients with a rare blood disorder have better transplant survival when disease burden is low, helping doctors identify who benefits most from this curative treatment.
Novel or significantly improved treatmentOutcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin…
Patients whose indolent lymphomas transform into aggressive forms achieve surprisingly better CAR-T cell therapy outcomes than those diagnosed aggressively upfront.
Early cancer detection or preventionPleural Fluid Outperforms Plasma for Detection of Clinically Relevant…
Testing lung fluid alongside blood dramatically improves detection of treatment-resistant cancer mutations, expanding access to targeted therapies for patients with fluid buildup.